Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Product Launch

18 Nov 2005 07:00

Original Investments PLC18 November 2005 Original Investments PLC ("Original Investments" or "the Company") Commercial product launch from Acrobot Visualisation software, enabling orthopaedic surgeons to producethree-dimensional bone surface models from Computed Tomography (CT) scans forpre-operative surgical planning, is launched today by The Acrobot Company("Acrobot"). Acrobot is a spin-out company from Imperial Innovations, the technologycommercialization company of Imperial College, London, and develops surgicalsystems for minimally-invasive, bone-conserving orthopaedic surgery. TheAIM-quoted company Original Investments (formerly BioProjects International)owns 25% of Acrobot's equity. The new software, called the Acrobot(R) Planner, is Acrobot's first commercialproduct and is being provided free of charge to surgeons who register to use it.Acrobot will receive fees for data preparation and bone modeling. The Acrobot(R) Planner gives the user the ability to visualise a patient's threedimensional bone surface models built from CT scans. The visualisation isinteractive and the user can select and position implant models onto the bones,evaluate the resulting range of motion, and produce reports. "The software will enable surgeons to assess accurately the exact requirementfor each operation and precisely plan the procedure beforehand," says Dr. PaulaGomes, Acrobot's Director of Operations. "It will help to reduce surgicalerrors, surgeon's stress, and overall procedure costs and times. Radiologistswill also use the software to produce enhanced reports." Further uses for the software will be as a powerful tool for teaching and alsogenerating visual material for presentations. Acrobot provides a commercial service for Acrobot(R) Planner users by taking theraw CT DICOM data, segmenting them and building bone surface models from theinformation. The user can import these patient-specific models into thesoftware, and perform hip resurfacing pre-operative surgical planning and/ orimpingement analysis. The data processing service removes the need for the userto be involved in time-consuming routine data preparation tasks. The Acrobot(R) Planner has been developed by the Acrobot team at the company'slaboratories in London's Leathermarket. It is the first of a number of relatedproducts to be produced by Acrobot, which was founded six years ago by ImperialInnovations as a collaboration to combine the skills of clinicians andacademics. Acrobot is initially focusing on developing precision surgical systems forminimally-invasive techniques in knee and hip replacement. With each product theoverall aims are to reduce error, increase accuracy and enable more difficultsculpted surfaces to be achieved for the new generation of 'resurfacing' orpartial joint implants. Products planned for launch in 2006 include the Acrobot(R) Navigation System,which provides visual guidance for the surgeon and is now undergoing regulatoryapproval, and the Acrobot Hands-On Robotic System, which has already beensuccessfully proven in clinic for unicompartmental knee arthroplasty. "We are delighted that our faith in Acrobot is beginning to bear commercialfruit," said Terry Bond, managing director of Original Investments. "Four yearsago we were the first investors outside Imperial College to provide seed-cornfunding for the company and we have continued to support it through the variousstages of its development." Further information on Original Investments PLC from Terry Bond, ManagingDirector, 01235 834734. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jul 20097:00 amRNSContract Win
23rd Jun 20093:06 pmRNSAdditional Listing
12th Jun 200910:55 amRNSBoard Change
1st Jun 200912:39 pmRNSExercise of Options & TVR
11th May 20094:10 pmRNSHolding(s) in Company
6th May 20094:04 pmRNSTrading Statement
5th May 20094:13 pmRNSHolding(s) in Company
5th May 20093:24 pmRNSExercise of Warrants
5th May 20097:00 amRNSTrading Statement
23rd Apr 20098:55 amRNSTrading Statement
21st Apr 200912:50 pmRNSResult of Warrantholder General Meeting
16th Apr 20098:49 amRNSTrading Statement
6th Apr 200911:56 amRNSHolding(s) in Company
2nd Apr 20097:00 amRNSIssue of Equity
1st Apr 20098:10 amRNSTrading Statement
23rd Mar 20097:00 amRNSTrading Statement
4th Mar 20091:33 pmRNSHolding(s) in Company
16th Jan 20098:31 amRNSTrading Statement
18th Dec 20089:19 amRNSWarrant Update
16th Dec 20087:00 amRNSTrading Statement
16th Dec 20087:00 amRNSHalf Yearly Report
29th Oct 200812:47 pmRNSResult of AGM
29th Oct 20087:00 amRNSOil Well Update
22nd Oct 20087:00 amRNSOil Exploration Drilling in Texas
7th Oct 200810:55 amRNSCancellation and re-issue of options
30th Sep 20087:00 amRNSFinal Results
29th Sep 20087:00 amRNSProjects Update
10th Sep 20089:00 amRNSHolding(s) in Company
1st Sep 200811:12 amRNSTotal Voting Rights
19th Aug 20084:14 pmRNSHolding(s) in Company
19th Aug 200812:40 pmRNSPlacing raises GBP1.8 million
18th Aug 200810:07 amRNSContract with ASTFS
14th Aug 200811:07 amRNSStrategic Agreement with Swan
6th Aug 20087:00 amRNSLA County Radiation Monitorin
21st Jul 20087:00 amRNSUpdate on Oil Reservoir Analy
17th Jul 20082:26 pmRNSHolding(s) in Company
1st Jul 20087:00 amRNSPartners with Texas group AST
18th Jun 20087:00 amRNSPartners with Atascosa Explor
29th May 20087:00 amRNSContract Win
1st Apr 20081:00 pmRNSViaLogy selected by Cisco
13th Mar 20082:10 pmRNSAdditional Listing
8th Feb 200810:02 amRNSAppointment of Broker
7th Feb 20087:00 amRNSProduct approval in US
30th Jan 20087:01 amRNSSenior Appointment
27th Dec 20077:00 amRNSInterim Results
30th Nov 20077:11 amRNSSenior appointment
30th Oct 20074:13 pmRNSResult of AGM
30th Oct 200710:02 amRNSAGM Statement
25th Oct 200710:59 amRNSGrant of options
28th Sep 20074:15 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.